194 related articles for article (PubMed ID: 18057011)
1. Central venous access port-related complications in outpatient chemotherapy for colorectal cancer.
Inaba Y; Yamaura H; Sato Y; Najima M; Shimamoto H; Nishiofuku H; Ura T; Muro K
Jpn J Clin Oncol; 2007 Dec; 37(12):951-4. PubMed ID: 18057011
[TBL] [Abstract][Full Text] [Related]
2. Central venous port system-related complications in outpatient chemotherapy for colorectal cancer.
Tsutsumi S; Fukasawa T; Fujii T; Tabe Y; Kigure W; Asao T; Kuwano H
Hepatogastroenterology; 2012 Jun; 59(116):1079-80. PubMed ID: 22580658
[TBL] [Abstract][Full Text] [Related]
3. [Outpatient chemotherapy of an advanced or metastatic colorectal cancer].
Sato T; Kokuba Y; Ozawa H; Hatate K; Nakamura T; Onosato W; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():257-9. PubMed ID: 17469353
[TBL] [Abstract][Full Text] [Related]
4. [The future of chemotherapy at home--from outpatient chemotherapy to chemotherapy at home].
Takahashi K
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():279-81. PubMed ID: 17469360
[TBL] [Abstract][Full Text] [Related]
5. [Our outpatient cases for home anti-cancer chemotherapy using a CV port and a portable pump system].
Midorikawa Y; Nakachi T; Kasuga T
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():264-6. PubMed ID: 17469355
[TBL] [Abstract][Full Text] [Related]
6. [Feasibility of peripheral vein during FOLFOX/FOLFIRI chemotherapy through peripheral venous system].
Kimura T; Iwase K; Aono T; Nakai S; Fujii M; Nishikawa K; Matsuda C; Shimada K; Hirota M; Nasu S; Wada D; Hasegawa J; Tanaka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1889-94. PubMed ID: 19011337
[TBL] [Abstract][Full Text] [Related]
7. The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients.
Sawayama H; Hayashi N; Watanabe M; Takamori H; Beppu T; Baba H
Surg Today; 2012 Jan; 42(1):29-34. PubMed ID: 22105529
[TBL] [Abstract][Full Text] [Related]
8. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
9. [Trial of "Huber Plus" in outpatients with chemotherapy by blood port system].
Matsumura N; Tazumi K; Kouji K; Kondo M; Mizuki M
Gan To Kagaku Ryoho; 2008 Mar; 35(3):539-41. PubMed ID: 18347413
[TBL] [Abstract][Full Text] [Related]
10. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases.
Heinrich S; Petrowsky H; Schwinnen I; Staib-Sebler E; Gog C; El-Ganainy A; Gutt C; Müller HH; Lorenz M
Surgery; 2003 Jan; 133(1):40-8. PubMed ID: 12563236
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
12. [Survey on the compliance of patients with continuous infusion of 5-fluorouracil via portable infusion pumps].
Sato J; Terui K; Awatsu A; Koyama M; Itoh J; Saijo Y; Hayakari M
Gan To Kagaku Ryoho; 2010 Apr; 37(4):671-5. PubMed ID: 20414024
[TBL] [Abstract][Full Text] [Related]
13. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
14. [Present status of home therapy cancer patients using an infusor].
Tsuji Y; Tsushima T; Tanaka S; Mizushima T; Tamura F; Chiba H; Honda K; Makino K; Ohura K; Sumiyoshi T; Yoshizaki N; Kondo H
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():260-3. PubMed ID: 17469354
[TBL] [Abstract][Full Text] [Related]
15. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V
Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
[TBL] [Abstract][Full Text] [Related]
18. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of catheter loops in central venous port systems.
Behrendt FF; Wingen M; Katoh M; Guenther RW; Buecker A
Invest Radiol; 2006 Nov; 41(11):777-80. PubMed ID: 17035867
[TBL] [Abstract][Full Text] [Related]
20. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.
Berretta M; Di Benedetto F; Bearz A; Simonelli C; Martellotta F; Del Ben C; Berretta S; Spina M; Tirelli U
Cancer Invest; 2008 Jul; 26(6):610-4. PubMed ID: 18584352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
